tvcn principal treatment centre children’s...
Post on 20-Aug-2020
2 Views
Preview:
TRANSCRIPT
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 1 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 2 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 3 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 4 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 5 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 6 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 7 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 8 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 9 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 10 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 11 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 12 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 13 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 14 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 15 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 16 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 17 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 18 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 19 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 20 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 21 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 22 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 23 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 24 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 25 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 26 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 27 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 28 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 29 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 30 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 31 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
TVCN Principal Treatment Centre Children’s Hospital Oxford
Filename: Blood Products
Page 32 of 32 Date agreed: August 2015
Issue date: August 2015
Version: 3.0 Agreed By: Chair Network Chemotherapy Group
Review date: August 2019
Children’s Cancer measure 11-7B-137
Author: Amrana Qureshi / Neha Bhatnagar
top related